{"title":"糖尿病患者的脂质改变","authors":"D. Morris","doi":"10.1002/psb.2053","DOIUrl":null,"url":null,"abstract":"Dyslipidaemia is an important risk factor in the development of atherosclerotic cardiovascular disease in people with diabetes. This article discusses the lipid modifying therapies available, and the current evidence and guidance on their use in diabetes.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lipid modification in people with diabetes\",\"authors\":\"D. Morris\",\"doi\":\"10.1002/psb.2053\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dyslipidaemia is an important risk factor in the development of atherosclerotic cardiovascular disease in people with diabetes. This article discusses the lipid modifying therapies available, and the current evidence and guidance on their use in diabetes.\",\"PeriodicalId\":88184,\"journal\":{\"name\":\"The Prescriber\",\"volume\":\"6 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Prescriber\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/psb.2053\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/psb.2053","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Dyslipidaemia is an important risk factor in the development of atherosclerotic cardiovascular disease in people with diabetes. This article discusses the lipid modifying therapies available, and the current evidence and guidance on their use in diabetes.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
